New US COVID-19 vaccine eyes Botswana licensing

Big plans: Dr Soon-Shiong hopes the Botswana vaccine plant will be up and running by 2026 PIC: WIKIMEDIA COMMONS
Big plans: Dr Soon-Shiong hopes the Botswana vaccine plant will be up and running by 2026 PIC: WIKIMEDIA COMMONS

A new COVID-19 vaccine technology that will be made available without patent restrictions, could soon apply for licensing in Botswana, helping the country kickstart production of its own lifesaving drugs.

Dubbed “the world’s COVID-19 vaccine” the new vaccine technology was developed by researchers at Texas Children’s Hospital and Baylor College of Medicine led by Drs Maria Elena Bottazzi and Peter Hotez.

The new vaccine uses traditional recombinant protein-based technology that will enable its production at large scale. At present, the most popular vaccines in the world and in Botswana use the mRNA technology and include those from Pfizer and Moderna.

Editor's Comment
BDP primaries leave a lot to be desired

The BDP as a party known to have ample resources has always held its primaries well in time, but this time around that was not the case. The first leg of the primaries was held last weekend, with the final leg being billed for the coming weekend. This time around, the BDP failed to shine in its primary elections. The elections were chaotic; most if not all polling stations didn't open at the specified time of 6am. Loyal BDP members braved the...

Have a Story? Send Us a tip
arrow up